LTS receives $4.3 Million grant for the development of contraceptive Microneedle Array Patches

Contributed by: PR Newswire

Tags

LTS-Lohmann-Therapie

More Like This

LTS receives grant of $1.2 Million to support the development of thermostable mRNA formulations for Microneedle Array Patches

LTS and Nualtis Announce Strategic Cooperation to Expand Global Manufacturing Capabilities, Accelerate Market Expansion, and Ensure Customer Success

First product based on LTS Sorrel™ wearable drug delivery platform launched in the US

PR Newswire associated0

Daewoong Pharmaceutical to Initiate Clinical Trials Early Next Year for Innovative 'GLP-1 Obesity Treatment' with Advanced Microneedle Technology for Sustained Weekly Efficacy

Dr Lara Zibners and Thang Vo-Ta co-founded the B-Corp inspired by Lara’s experience from multiple failed IVF cycles.

Pioneering tech to address threatened miscarriage secures NIHR grant to advance clinical trials

LifeArc makes multi-million pound investment to support drug discovery in sub-Saharan Africa

L&T Technology Services Collaborates With NVIDIA to Unveil Gen AI and Advanced Software-Defined Architecture for Medical Devices

PR Newswire associated0

MTD Group completes the acquisition of Ypsomed's Pen Needles and Blood Glucose Monitoring Systems and announces a significant investment plan for its European production sites